{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:29:03Z","timestamp":1786768143679,"version":"build-2736575974"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,8,15]]},"DOI":"10.2169\/internalmedicine.6638-25","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T22:08:21Z","timestamp":1768428501000},"page":"2280-2285","source":"Crossref","is-referenced-by-count":0,"title":["Eosinophilic Granulomatosis with Polyangiitis Complicated by Eosinophilic Chronic Rhinosinusitis Successfully Treated with Combination of Mepolizumab and Dupilumab"],"prefix":"10.2169","volume":"65","author":[{"given":"Hirotake","family":"Inomata","sequence":"first","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Asatani","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Uchikawa","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Sugito","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishihara","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Akiya","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Oshima","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 78: 26-37, 1999.","DOI":"10.1097\/00005792-199901000-00003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Koike H, Nishi R, Ohyama K, et al. ANCA-associated vasculitic neuropathies: a review. Neurol Ther 11: 21-38, 2022.","DOI":"10.1007\/s40120-021-00315-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Koike H, Furukawa S, Mouri N, Fukami Y, Iijima M, Katsuno M. Early ultrastructural lesions of anti-neutrophil cytoplasmic antibody- versus complement-associated vasculitis. Neuropathology 42: 420-429, 2022.","DOI":"10.1111\/neup.12821"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Koike H, Nishi R, Furukawa S, et al. In vivo visualization of eosinophil secretion in eosinophilic granulomatosis with polyangiitis: an ultrastructural study. Allergol Int 71: 373-382, 2022.","DOI":"10.1016\/j.alit.2022.02.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. White J, Dubey S. Eosinophilic granulomatosis with polyangiitis: a review. Autoimmun Rev 22: 103219, 2023.","DOI":"10.1016\/j.autrev.2022.103219"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sada KE, Suzuki T, Joksaite S, et al. Trends in prevalence, treatment use, and disease burden in patients with eosinophilic granulomatosis with polyangiitis in Japan: real-world database analysis. Mod Rheumatol 34: 988-998, 2024.","DOI":"10.1093\/mr\/road104"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mahr A, Moosig F, Neumann T, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management. Curr Opin Rheumatol 26: 16-23, 2014.","DOI":"10.1097\/BOR.0000000000000015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Comarmond C, Pagnoux C, Khellaf M, et al.; the French Vasculitis Study Group. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow up of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65: 270-281, 2013.","DOI":"10.1002\/art.37721"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gomes L, Santos SD, Pereira S, Rua J, Fortuna J. Sinusitis and late-onset asthma: a red flag of Eosinophilic Granulomatosis with polyangiitis. Cureus 15: e35512, 2023.","DOI":"10.7759\/cureus.35512"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cai S, Lou H, Zhang L. Prognostic factors for post-operative outcomes in chronic rhinosinusitis with nasal polyps: a systematic review. Expert Rev Clin Immunol 19: 867-881, 2023.","DOI":"10.1080\/1744666X.2023.2218089"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bachert C, Sousa AR, Han JK, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count. J Allergy Clin Immunol 149: 1711-1721, 2022.","DOI":"10.1016\/j.jaci.2021.10.040"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nishisaka K, Ueda Y, Inoue M, Ishikawa M, Kageyama G, Saegusa J. Three cases of relapsed eosinophilic sinusitis without eosinophilia during mepolizumab maintenance therapy for eosinophilic granulomatosis with polyangiitis. Clin Rheumatol 43: 3577-3580, 2024.","DOI":"10.1007\/s10067-024-07133-w"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394: 1638-1650, 2019.","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33: 1065-1167, 1990.","DOI":"10.1002\/art.1780330806"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Grayson PC, Ponte C, Suppiah R, et al.; DCVAS Study Group. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis. Ann Rheum Dis 81: 309-314, 2022.","DOI":"10.1002\/art.41982"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wechsler ME, Akuthota P, Jayne D, et al.; the EGPA Mepolizumab Study Team. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med 376: 1921-1932, 2017.","DOI":"10.1056\/NEJMoa1702079"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Tokunaga T, Sakashita M, Haruna T, et al. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy 70: 995-1003, 2015.","DOI":"10.1111\/all.12644"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Eschenbacher W, Straesser M, Knoeddler A, Li RC, Borish L. Biologics for the treatment of allergic rhinitis, chronic rhinosinusitis, and nasal polyposis. Immunol Allergy Clin North Am 40: 539-547, 2020.","DOI":"10.1016\/j.iac.2020.06.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nagase H, Ueki S, Fujieda S. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergol Int 69: 178-186, 2020.","DOI":"10.1016\/j.alit.2020.02.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Fujieda S, Imoto Y, Kato Y, et al. Eosinophilic chronic rhinosinusitis. Allergol Int 68: 403-412, 2019.","DOI":"10.1016\/j.alit.2019.07.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fahy JV. Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol 15: 57-65, 2015.","DOI":"10.1038\/nri3786"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378: 2486-2496, 2018.","DOI":"10.1056\/NEJMoa1804092"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Simpson EL, Bieber T, Guttman-Yassky E, et al.; the SOLO 1 and SOLO 2 Investigators. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 375: 2335-2348, 2016.","DOI":"10.1056\/NEJMoa1610020"},{"key":"24","unstructured":"24. Vangipuram R, Tyring SK. Dupilumab for moderate-to-severe atopic dermatitis. Skin Therapy Lett 22: 1-4, 2017."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Matucci A, Bormioli S, Bercich L, et al. Effect of dupilumab treatment in a severe asthma patient with EGPA. J Allergy Clin Immunol Pract 9: 3824-3825, 2021.","DOI":"10.1016\/j.jaip.2021.06.033"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Caminati M, Olivieri B, Dama A, et al. Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management. Expert Rev Respir Med 16: 713-721, 2022.","DOI":"10.1080\/17476348.2022.2090342"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Iwadate Y, Arinuma Y, Matsueda Y, et al. A case of dupilumab combination therapy for exacerbation of atopic dermatitis in a patient with eosinophilic granulomatosis with polyangiitis treated with mepolizumab. Mod Rheumatol Case Rep 8: 159-162, 2023.","DOI":"10.1093\/mrcr\/rxad059"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Anai M, Yoshida C, Ozono K, et al. Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis. Allergol Int 71: 259-261, 2022.","DOI":"10.1016\/j.alit.2021.11.003"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/16\/65_6638-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:11:44Z","timestamp":1786767104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/16\/65_6638-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":28,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6638-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"article-number":"6638-25"}}